Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis
Journal of International Medical Research · 2023-10 · 51 (10)
DOI: 10.1177/03000605231204469 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of International Medical Research, online erschienen am 17.10.2023. Verfasst von Mehrbod Vakhshoori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Coronary Artery Disease, Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Inflammatory biomarkers are novel tools to assess the prognosis of different cardiovascular diseases. We evaluated the impact of the monocyte-to-lymphocyte ratio (MLR) on clinical outcomes in patients with coronary heart disease (CHD).
Methods
We systematically screened English-language articles in PubMed, Scopus, and Web of Science to 31 August 2022. Relevant articles reporting the MLR and its association with clinical outcomes (major adverse cardiovascular events (MACE), coronary artery disease (CAD) severity, mortality, cardiac rupture, subclinical CAD, acute coronary syndrome (ACS) prediction, thin-cap fibroatheroma, no-reflow phenomenon, MLR-related differences in percutaneous coronary intervention, heart failure hospitalization, and depression) in patients with CHD were collected for further analysis.
Results
Nineteen articles were selected. The mean MLR was 0.34. A higher MLR was significantly associated with an increased risk of MACE among patients with CHD. The MLR was an independent predictor of MACE in patients with ACS. No significant association was found for CAD severity. A complementary analysis was not performed because of few studies focusing on the other predefined endpoints.
Conclusions
The MLR is a simple and widely available tool to predict MACE in patients with CHD. This biomarker can be utilized in emergency settings to prioritize high-risk patients and optimize therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
- School of Medicine, Tehran Azad University of Medical Sciences, Tehran, Iran.
- Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Mehrbod Vakhshoori
Zitieren
APA
Vakhshoori, M., Nemati, S., Sabouhi, S., Shakarami, M., Yavari, B., Emami, S. A., Bondariyan, N., & Shafie, D. (2023). Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis. Journal of International Medical Research, 51(10). https://doi.org/10.1177/03000605231204469
Vancouver
Vakhshoori M, Nemati S, Sabouhi S, Shakarami M, Yavari B, Emami SA, et al. Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis. Journal of International Medical Research. 2023;51(10). doi:10.1177/03000605231204469
BibTeX
@article{Vakhshoori2023,
author = {Vakhshoori, Mehrbod and Nemati, Sepehr and Sabouhi, Sadeq and Shakarami, Mehrnaz and Yavari, Behzad and Emami, Sayed Ali and Bondariyan, Niloofar and Shafie, Davood},
title = {Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis},
journal = {Journal of International Medical Research},
year = {2023},
volume = {51},
number = {10},
doi = {10.1177/03000605231204469}
}
EUVIMED